BOZEMAN DEACONESS CANCER CENTER CHOSEN AS CLINICAL RESEARCH SITE
JUNE 21, 2012Bozeman may be far from major metropolitan medical centers but that doesn't prevent our patients from accessing the latest in cutting edge cancer care. Through its affiliation with Seattle Cancer Care Alliance, Bozeman Deaconess Cancer Center recently was invited, by the National Comprehensive Cancer Network® (NCCN®) to join NCCN’s Affiliate Research Project (ARP) and offer as many as 50 new clinical cancer research trials to the trials already available to their patients.
“Only seven affiliates were chosen to participate, from among all the cancer centers across the country,” said Spencer Green, Business Operations Manager for Bozeman Deaconess Cancer Center.
NCCN’s ARP, developed by NCCN’s Oncology Research Program (ORP), is designed to improve patient outcomes and advance medical science through collaborations with 21 member institutions and their community-based affiliate networks to give community researchers access to innovative therapies. Once nominated for affiliation, Bozeman Deaconess Cancer Center had a site visit from NCCN investigators to talk with doctors, tour the facilities and determine if the site was suitable for research projects headed up by some of the country’s top cancer investigators.
Added Green, “This offers our patients another opportunity to receive cutting edge treatment without requiring them to travel to a large city, where many of these trials originate.”
SIGN UP FOR OUR PATIENT PORTAL
PATIENT PORTAL GETTING STARTED
As a patient of Bozeman Deaconess Health Group, you can now access important information in your medical record, request an appointment, and communicate with your medical office team online, with the click of a button, anytime of the day or night.
Go To Patient Portal